139 related articles for article (PubMed ID: 14600530)
1. Acute tubular necrosis in a patient receiving tenofovir.
Lee JC; Marosok RD
AIDS; 2003 Nov; 17(17):2543-4. PubMed ID: 14600530
[No Abstract] [Full Text] [Related]
2. Tenofovir-related nephrotoxicity in HIV-infected patients.
Barrios A; García-Benayas T; González-Lahoz J; Soriano V
AIDS; 2004 Apr; 18(6):960-3. PubMed ID: 15060449
[No Abstract] [Full Text] [Related]
3. Renal lesions in HIV-1-positive patient treated with tenofovir.
Créput C; Gonzalez-Canali G; Hill G; Piketty C; Kazatchkine M; Nochy D
AIDS; 2003 Apr; 17(6):935-7. PubMed ID: 12660548
[No Abstract] [Full Text] [Related]
4. Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?
Saumoy M; Vidal F; Peraire J; Sauleda S; Vea AM; Viladés C; Ribera E; Richart C
AIDS; 2004 Aug; 18(12):1741-2. PubMed ID: 15280790
[No Abstract] [Full Text] [Related]
5. Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome.
Schaaf B; Aries SP; Kramme E; Steinhoff J; Dalhoff K
Clin Infect Dis; 2003 Aug; 37(3):e41-3. PubMed ID: 12884188
[TBL] [Abstract][Full Text] [Related]
6. Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir.
Callens S; De Roo A; Colebunders R
J Infect; 2003 Oct; 47(3):262-3. PubMed ID: 12963392
[No Abstract] [Full Text] [Related]
7. Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment.
Callens S; De Schacht C; Huyst V; Colebunders R
J Infect; 2003 Aug; 47(2):188-9. PubMed ID: 12860159
[No Abstract] [Full Text] [Related]
8. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
Herlitz LC; Mohan S; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Kidney Int; 2010 Dec; 78(11):1171-7. PubMed ID: 20811330
[TBL] [Abstract][Full Text] [Related]
9. [Lipid profile and body fat--significant "side effect" of antiretroviral therapy. Tenofovir: favorable profile of adverse effects].
MMW Fortschr Med; 2003 Apr; 145 Spec No 1():83. PubMed ID: 15011603
[No Abstract] [Full Text] [Related]
10. Marked elevation of the creatine phosphokinase level in a patient receiving tenofovir.
Shere-Wolfe KD; Verley JR
Clin Infect Dis; 2002 Nov; 35(9):1137. PubMed ID: 12384851
[No Abstract] [Full Text] [Related]
11. ASN clinical pathological conference. Tenofovir-related ATN (severe).
Atta MG; Stokes MB
Clin J Am Soc Nephrol; 2013 May; 8(5):882-90. PubMed ID: 23371959
[No Abstract] [Full Text] [Related]
12. Tenofovir disoproxil fumarate.
Kumar A
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887267
[No Abstract] [Full Text] [Related]
13. EU issues warning about HAART regimen.
AIDS Patient Care STDS; 2004 Jan; 18(1):56-7. PubMed ID: 15080094
[No Abstract] [Full Text] [Related]
14. Warning issued on non-response rates.
AIDS Patient Care STDS; 2003 Oct; 17(10):539. PubMed ID: 14588094
[No Abstract] [Full Text] [Related]
15. Tenofovir disoproxil fumarate.
Antoniou T
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887266
[No Abstract] [Full Text] [Related]
16. Evolution of lipid abnormalities in patients switched from stavudine- to tenofovir-containing regimens.
Lafeuillade A; Jolly P; Chadapaud S; Hittinger G; Lambry V; Philip G
J Acquir Immune Defic Syndr; 2003 Aug; 33(4):544-6. PubMed ID: 12869846
[No Abstract] [Full Text] [Related]
17. Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution.
Gaspar G; Monereo A; García-Reyne A; de Guzmán M
AIDS; 2004 Jan; 18(2):351-2. PubMed ID: 15075563
[No Abstract] [Full Text] [Related]
18. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy.
Perazella MA
Kidney Int; 2010 Dec; 78(11):1060-3. PubMed ID: 21076445
[TBL] [Abstract][Full Text] [Related]
19. Does tenofovir increase efavirenz hepatotoxicity?
Lattuada E; Lanzafame M; Carolo G; Gottardi M; Concia E; Vento S
AIDS; 2008 May; 22(8):995. PubMed ID: 18453862
[No Abstract] [Full Text] [Related]
20. Renal safety of tenofovir in HIV treatment-experienced patients.
Izzedine H; Isnard-Bagnis C; Hulot JS; Vittecoq D; Cheng A; Jais CK; Launay-Vacher V; Deray G
AIDS; 2004 Apr; 18(7):1074-6. PubMed ID: 15096814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]